Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease

Surgery

Volumn 133, Issue 1, 2003, Pages 5-12

  Liu, Jean Y ^a,b   Finlayson, Samuel R G ^a,b   Laycock, William S ^a,b   Rothstein, Richard I ^a,b   Trus, Thadeus L ^a,b   Pohl, Heiko ^a,b   Birkmeyer, John D ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; DECISION THEORY; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PATIENT REFERRAL; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RATING SCALE; REOPERATION; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL MODEL; SURGICAL RISK; TREATMENT FAILURE;

EID: 0037263495     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.122     Document Type: Article

References (52)

1. Behar J, Sheahan D, Biancani P, Spinro H, Storer E. Medical and surgical managment of reflux esophagitis. N Engl J Med 1975;293:263-8.
2. Spechler SJ for the Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786-92.
3. Spechler S, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
4. Lundell L, Miettinen P, Myrvold H, Pedersen SA, Thor K, Lamm M, et al. Long-term management of gastrooesophageal reflux disease with omeprazole or open antire-flux surgery, results of a prospective, randomized clinical trial. Eur J Gastroenterol 2000;12:879-87.
5. Bammer T, Hinder R, Klaus A, Klinger P. Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 2001;5:42-8.
6. Liu J, Wolosin S, Laycock W, Schwartz L. Late outcomes after laparoscopic surgery for gastroesophageal reflux. Arch Surg 2002;137:397-401.
7. Finlayson S, Birkmeyer J, Laycock W. Trends in surgery for gastroesophageal reflux disease: the effect of laparoscopic surgery on utilization. Annual Meeting of the International Society of Technology Assessment in Health Care. Philadelphia, Pa; June 2001.
8. Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38.
9. DATA 3.5. 3.5 ed. Williamstown, MA: TreeAge Software, Inc; 1999.
10. Torrance G. Utility apporach to measuring health-related quality of life. J Chronic Dis 1987;40:593-600.
11. The National Center for Health Statistics. Report of final mortality statistics. Vol 47, no. 7. Washington, DC: US Public Health Service; 1996.
12. Lipscomb J, Weinstein MC, Torrance GW. In: Gold M, Siefel J, Russell L, Weinstein M, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. p. 214-46.
13. Baladi J, Menon D, Otten N. An economic evluation of finesteride for treatment of benign prostatic hyperplasia. Pharmacoeconomics 1996;9:443-54.
14. Sculpher M, Michaels J, McKenna M. A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusion. Int J Technol Assess Health Care 1996;12:104-25.
15. Johnson J, Coons S, Ergo A, Szava-Kovats G. Valuation of EuroQol (EQ-5D) health states in an adult US sample. Pharmacoeconomics 1998;4:421-33.
16. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
17. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 Health Survey questionnaire. Qual Life Res 1993;2:169-80.
18. Llach X, Herdman M, Schiaffino A. Determining correspondence between scores on the EQ-5D "Thermometer" and a 5-point categorical rating scale. Med Care 1999;37:671-7.
19. Nease R, Kneeland T, O'Connor G, Sumner W, Lumpkins L, Shaw L, et al. Variation in patient utilites for outcomes of the managment of chronic stable angina. JAMA 1995; 273:1185-90.
20. Llewellyn-Thomas H Sutherland H, Tibshirani R, Ciampi A, Till J, Boyd N. Describing health states: methodologic issues in obtaining values for health states. Med Care 1984;22:543-52.
21. Read J, Quinn R, Berwick D, Fineberg H, Weinstein M. Preferences for health outcomes: comparison of assessment methods. Med Decis Making 1984;4:315-29.
22. Heudebert GR, Marks R, Wilcox M, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastoenterol 1997;112:1078-86.
23. Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 2001;49:488-94.
24. Lundell L, Dalenback J, Janatuinen E, Hattlebakk J, Levander K, Miettinen P, et al. Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. Br J Surg 1998;85:1002-5.
25. Bloomston M, Zervos E, Gonzalez R, Albrink M, Rosemurgy A. Quality of life and antireflux medication use following laparoscopic Nissen fundoplication. Am Surg 1998;64:509-14.
26. Heikkinen T, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Sodervik H, et al. Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with 3-month followup. J Am Coll Surg 1999;188:368-76.
27. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastoenterol 1997;32:766-72.
28. Van Den Boom G, Go PMMYH, Hameeteman W, Dallemagne B. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophgeal reflux disease in The Netherlands. Scand J Gastoenterol 1996;31:1-9.
29. Hinder R, Filipi C, Wetscher G, Neary P, DeMeester T, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472-83.
30. Collett D, Cadiere G. Conversions and complications of laparoscopic treatment of gastroesophageal reflux disease: formation for the Development of Laparoscopic Surgery for Gastroesophageal Reflux Disease Group. Am J Surg 1995;169:622-6.
31. Medina L, Veintimilla R, Williams M, Fenoglio M. Laparoscopic fundoplication. J Laparoendosc Surg 1996; 6:219-26.
32. Cadiere G, Himpens J, Rajan A, Muls V, Lemper JC, Bruyns J, et al. Laparoscopic Nissen fundoplication: laparoscopic dissection technique and results. Hepatogastroenterology 1997;44:4-10.
33. Fingerhut A, Etienne J, Millat B, Comandella M. Laparoscopic antireflux surgery - technique and results. Therapeutische Umschau 1997;54:492-9.
34. Landreneau R, Wiechmann R, Hazelrigg S, Santucci TS, Boley TM, Magee MJ, et al. Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg 1998;66:1886-93.
35. Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg 1998;228:40-50.
36. Ritter M, Peters J, DeMeester T, Crookes PF, Mason RJ, Green L, et al. Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter. J Gastrointest Surg 1998;2:567-72.
37. Hunter J, Smith C, Branum G, Waring JP, Trus TL, Cornwell M, et al. Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg 1999;230:595-9.
38. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: analysis of 5502 operations. Br J Surg 1999;86:1573-7.
39. Soper N, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999; 229:669-75.
40. Bais JE, Bartelsman JFWM, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC, et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. Lancet 2000;355:170-4.
41. Rattner DW, Brooks DC. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995;130:289-94.
42. Dallemagne B, Weerts J, Jehaes C, Markiewicz S. Causes of failures of laparoscopic antireflux operations. Surg Endosc 1996;10:305-10.
43. Stein H, Feussner H, Siewert J. Failure of antireflux surgery: causes and management strategies. Am J Surg 1996;171:36-40.
44. Curet MJ, Josloff RK, Schoeb O, Zucker KA. Laparoscopic reoperation for failed antireflux procedures. Arch Surg 1999;134:559-63.
45. Floch N, Hinder R, Klingler P, Branton SA, Seelig MH, Bammer T, et al. Is laparoscopic reoperation for failed antireflux surgery feasible? Arch Surg 1999;134:733-7.
46. Horgan S, Phol D, Bogetti D, Eubanks R, Pellegrini C. Failed antireflux surgery: what have we learned from reoperation? Arch Surg 1999;134:809-17.
47. Pointner R, Bammer T, Then P, Kamolz T. Laparoscopic refundoplications after failed antireflux surgery. Am J Surg 1999;178:541-4.
48. Bass E, Steinberg E, Pitt H. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Gastoenterol 1991;101:189-99.
49. Wong J, Koff B, Rine F. Cost-effectiveness of interferon-alpha-2b treatment for hepatitis B'e antigen-positive chornic hepatitis B. Ann Intern Med 1995;122:664-75.
50. Kellett J, Clarke J. Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatment of suspected acute myocardial infarction. Med Decis Making 1995;15:297-310.
51. Sarasin F, Eckman M. Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business. J Gen Intern Med 1993;8:476-86.
52. Danese M, Powe N, Sawin C. Screening for mild thyroid failure at the periodic health examination. JAMA 1996;276: 285-92.